Funding Rounds
Complement Therapeutics

Complement Therapeutics Series A (2023, $78M)

Complement Therapeutics

Preclinical stage treatment for geographic atrophy.

View Company Profile

GET THE TOP 10 COMPANIES OF THE WEEK IN YOUR EMAIL, EVERY TUESDAY.

OR DOWNLOAD OUR DATABASE OF 17,000 COMPANIES →

Summary

Stage: Series A

Raised Amount: $78.97M

Investors